-
Kelly West lecturer outlines next steps for more precise definitions, preventions, and treatments for type 2 diabetes
Mohammed K. Ali, MD, MSc, MBA, who was being honored for his contributions to diabetes epidemiology, said the field is poised to move beyond a “one-size-fits-all” approach to diabetes public health policies.
-
Experts to highlight innovative solutions for diabetes screening
Ines Casanova, PhD, and other presenters will explore strategies for closing diabetes screening gaps, including the findings from an ongoing initiative that deploys community health workers with mobile pop-up units into select areas.
-
Year in Review symposium to deliver the latest discoveries in diabetes
Anne Peters, MD, will highlight major advances and discoveries in the clinical science of diabetes, including expanding treatment and technology options. Raghu Mirmira, MD, PhD, will summarize translational progress, and Barbara Kahn, MD, will share basic science developments.
-
Authors to explain updates to new consensus statement on managing hyperglycemia in type 2 diabetes
Jennifer Green, MD, and others involved in updating the guidance from the ADA and the European Association for the Study of Diabetes, will discuss the rationale behind the shifting emphasis on assessing and changing behaviors and medications to improve outcomes over a person’s lifespan.
-
Presenter Profile: New York Regional CDTR: Bridging Clinic, Home, and School—A Community Health Worker Model to Support Families and Improve Diabetes Technology Use For Youth with Type 1 Diabetes
Charlotte Chen, DO, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.
-
Presenter Profile: Sexual Dimorphism in the Setting of Type 1 Diabetes
Raghavendra Mirmira, MD, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 6, at Saturday, December 30 CT.
-
Presenter Profile: Leveraging Multimodal Monitoring to Ascertain Intraindividual Diabetes Subphenotypes
Jessilyn Dunn, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 8:00 a.m. CT.
-
Presenter Profile: Leveraging Artificial Intelligence for Precision Medicine in Youth-Onset Type 2 Diabetes
Mustafa Tosur, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 8:00 a.m. CT.
-
Presenter Profile: Understanding Diabetes Heterogeneity via Mining Multimodality Interconnected Data
Carl Yang, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 8:00 a.m. CT.
-
Investigators to bring data on glucose management with oral orforglipron
Julio Rosenstock, MD, Francesco Giorgino, MD, PhD, and other panelists will discuss results from the ACHIEVE clinical trials, including ACHIEVE-3, which compared oral semaglutide and orforglipron for use in type 2 diabetes.